<!DOCTYPE html>
<html manifest="manifest.manifest">
<head>
	<meta http-equiv=Content-Type content="text/html; charset=utf-8">
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
  
	<meta name=Generator content="Microsoft Word 14 (filtered)">
		<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<link rel="stylesheet" href="mystyle.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>
	<script>
	    		$(function(){
			$("[data-role='header'], [data-role='footer']").toolbar();
		});
  	  $(document).one('pagebeforecreate', function () {
	        $('input[data-type="search"]').val("");
	    	        $.get("panel.html", function (data2) {
            $.mobile.pageContainer.prepend(data2);
              $("[data-role=panel]").panel().enhanceWithin();
        }, "html");
	           $.get("header.html", function (data) {
      $.mobile.pageContainer.prepend(data);
      $("[data-role='header']").toolbar().enhanceWithin();
    }, "html");
    $.get("footer.html", function (data) {
      $.mobile.pageContainer.append(data);
      $("[data-role='footer']").toolbar().enhanceWithin();
    }, "html");
        $('.WordSection1').wrap('<div role="main" class="ui-content">');
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $.mobile.pageContainer.enhanceWithin();
	  });
	        $(document).bind( "pagechange", function( ) {
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $('.tableCont').enhanceWithin();
      } );
			// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}</script>      
	




  	
</head>
<body lang=EN-GB link=blue vlink=purple>
	
<div data-role="page">
	<div role="main" class="ui-content">
<div class=WordSection1>
<h1><span lang=EN-US>Deep Vein Thrombosis and Pulmonary Embolism</span></h1>
<h2><span lang=EN-US>Executive summary</span></h2>
<h2><span lang=EN-US>Introduction</span></h2>
<p class=MsoNormal style='margin-bottom:11.4pt'><span lang=EN-US>Deep venous
thrombosis (DVT) and pulmonary embolism (PE) are both manifestations of venous
thromboembolism. DVT can be defined as the formation of a blood clot (thrombus)
within a deep vein, with the most common site of affectation being the lower
limbs. PE, on the other hand, is a potentially life-threatening complication of
DVT in which the thrombus formed becomes dislodged and migrates to occlude an
artery within the lung. </span></p>
<h2><span lang=EN-US>Target users</span></h2>
<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormalCxSpFirst style='margin-right:13.35pt;margin-bottom:.25pt;
     line-height:103%'><span lang=EN-US>Nurses</span></li>
 <li class=MsoNormalCxSpMiddle style='margin-right:13.35pt;margin-bottom:.25pt;
     line-height:103%'><span lang=EN-US>Doctors</span></li>
</ul>
<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
9.95pt;margin-left:0cm;line-height:107%;page-break-after:avoid'><b><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>Target area of use </span></b></p>
<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormalCxSpMiddle style='margin-right:13.35pt;margin-bottom:.25pt;
     line-height:103%'><span lang=EN-US>Gate Clinic</span></li>
 <li class=MsoNormalCxSpMiddle style='margin-right:13.35pt;margin-bottom:.25pt;
     line-height:103%'><span lang=EN-US>Outpatient Department</span></li>
 <li class=MsoNormalCxSpLast style='margin-right:13.35pt;margin-bottom:.25pt;
     line-height:103%'><span lang=EN-US>Ward</span></li>
</ul>
<h2><span lang=EN-US>Key areas of focus / New additions / Changes </span></h2>
<p class=MsoNormal style='margin-top:0cm;margin-right:13.35pt;margin-bottom:
.25pt;margin-left:0cm;line-height:103%'><span lang=EN-US>This guideline
provides information on the diagnosis and treatment of deep vein thrombosis and
pulmonary embolism. A large proportion of patients with pulmonary embolism are
asymptomatic. History and examination should seek for risk factures and
clinical features of these conditions. The Wells scoring systems should be used
to assess clinical probability of DVT and PE respectively. Patients should be
initially managed on the ward with heparin, warfarin (non-pregnant patients
only) and supportive care. Anticoagulation status should be reviewed using
coagulation studies. Warfarin if used should be given for at least 3 months.</span></p>
<h2><span lang=EN-US>Limitations</span></h2>
<p class=MsoNormal style='margin-bottom:8.0pt;line-height:107%'><span
lang=EN-US>Facilities for monitoring and treating venous thromboembolism are
not available at Keneba and Basse. Patients presenting there with these
conditions should be stabilized and referred.</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Presenting symptoms and signs</span></h2>
<p class=MsoNormal><span lang=EN-US>Risk factors for venous thromboembolism
should be ruled out.</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Malignancy</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Prolonged bed rest</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Smoking</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Stroke</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Obesity</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Pregnancy</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Recent long-distance travel</span></p>
<p class=MsoNormal><span lang=EN-US>Symptoms and signs of DVT usually occur
distal to the site of venous occlusion and include:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Pain in affected limb: occurs in about 50% of
cases</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Limb swelling: most specific symptom. DVT should
be ruled out in all patients presenting with unilateral pedal swelling</span></p>
<p class=MsoNormal><span lang=EN-US>In as many as 40% of patients, PE is silent
without obvious symptoms. Those who are symptomatic may present with sudden
onset of:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Shortness of breath</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Chest pain worse on inspiration</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Haemoptysis</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Cough </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Syncope </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Death</span></p>
<h2><span lang=EN-US>Examination findings</span></h2>
<p class=MsoNormal><span lang=EN-US>In suspected DVT, a general examination
should be carried out, followed by examination of the affected limb. Presence
of any of the following should raise suspicion of the presence of a DVT.</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Unilateral pitting oedema</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Homans sign: calf pain on foot dorsiflexion with
the knee extended</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Pratt sign: Tenderness over calf muscle on
palpation</span></p>
<p class=MsoNormal><span lang=EN-US>PE may present with:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Deranged vitals:</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Low saturation of oxygen</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Tachypnea</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Tachycardia</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Hypotension</span></p>
<p class=MsoNormal><span lang=EN-US>Chest examination </span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Maybe normal in the majority of patients. </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Occasionally, a pleural friction rub may be
heard over the affected area</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>Cardiovascular examination (may be normal
apart from tachycardia):</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Parasternal heave</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Loud pulmonary component of the second heart
sound</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Raised jugular venous pressure</span></p>
<h3><span lang=EN-US>Wells scores</span></h3>
<p class=MsoNormal><span lang=EN-US>If the diagnosis of DVT is suspected
following history and physical examination, the two-level DVT Wells score
should be used to estimate the clinical probability of DVT.</span></p>
<p class=MsoNormal><i><span lang=EN-US>Two-Level DVT Wells Score</span></i></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Clinical Feature</span></b></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Points</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Active cancer (treatment ongoing, within
  6 months or palliative)</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>1</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Paralysis, paresis or recent plaster
  immobilization of the lower extremities</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>1</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Recently bedridden for 3 days or more or
  major surgery within 12 weeks requiring general or regional anaesthesia</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>1</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Localized tenderness along the
  distribution of the deep venous system</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>1</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Entire leg swollen</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>1</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Calf swelling at least 3cm larger than
  asymptomatic side</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>1</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Pitting oedema confined to the
  asymptomatic leg</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>1</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Collateral superficial veins
  (non-varicose)</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>1</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Previously documented DVT</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>1</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Alternative diagnosis at least as likely
  as a DVT</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>-2</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><i><span lang=EN-US>Interpretation:</span></i></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=312 valign=top style='width:233.75pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>DVT Likely</span></p>
  </td>
  <td width=312 valign=top style='width:233.75pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>2 Points Or More</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:233.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>DVT Unlikely</span></p>
  </td>
  <td width=312 valign=top style='width:233.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>1 Point Or Less</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>If the diagnosis of PE is suspected
following history and physical examination, the two-level PE Wells score should
be used to estimate the clinical probability of PE.</span></p>
<p class=MsoNormal><i><span lang=EN-US>Two-Level PE Well’s Score</span></i></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Clinical Feature</span></b></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Points</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Clinical signs and symptoms of DVT
  (minimum of leg swelling and pain with palpation of the deep veins)</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US>3</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>An alternative diagnosis is less likely
  than PE</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US>3</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Heart rate &gt;100&nbsp;beats per minute</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US>1.5</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Immobilisation for more than 3&nbsp;days
  or surgery in the previous 4&nbsp;weeks</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US>1.5</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Previous DVT/PE</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US>1.5</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Hemoptysis</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US>1</span></p>
  </td>
 </tr>
 <tr>
  <td width=504 valign=top style='width:377.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Malignancy (on treatment, treated in the
  last 6&nbsp;months, or palliative)</span></p>
  </td>
  <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US>1</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><i><span lang=EN-US>Interpretation:</span></i></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=312 valign=top style='width:233.75pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>PE Likely</span></p>
  </td>
  <td width=312 valign=top style='width:233.75pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>More Than 4 Points</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:233.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>PE Unlikely</span></p>
  </td>
  <td width=312 valign=top style='width:233.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>4 Points Or Less</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<h2><span lang=EN-US>Differential diagnoses</span></h2>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Cellulitis </span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Lymphoedema </span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Soft tissue injury</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Dependent oedema</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Congestive cardiac failure</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Renal failure</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nephritic syndrome</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Swelling in a paralysed limb </span></p>
<h2><span lang=EN-US>Investigations</span></h2>
<p class=MsoNormal><span lang=EN-US>All patients with suspected DVT should be
offered:</span></p>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doppler ultrasonography: to confirm the presence
of a clot</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Coagulation studies: INR, PT, PTTK to
investigate for hypercoagulability if indicated.</span></p>
<p class=MsoNormal><span lang=EN-US>In suspected PE, the following should be
done:</span></p>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>CXR: findings might include: Enlarged pulmonary
artery(Fleischner sign), peripheral wedge of airspace opacity which implies
lung infarction(Hampton’s Hump), regional oligaemia (Westermark sign)  or <a
href="https://radiopaedia.org/articles/pleural-effusion"><span
style='color:windowtext;text-decoration:none'>pleural effusion</span></a>&nbsp;</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>ECG: May show sinus tachycardia (most common), right
heart strain pattern: seen as a right bundle branch block pattern or right axis
deviation or S<sub>I</sub>Q<sub>III</sub>T<sub>III</sub>&nbsp;pattern: this
refers to a deep S wave in lead I, Q wave and T wave inversion in lead III</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Echocardiography: Right ventricular wall
hypokinesis, right ventricular dilatation, and pulmonary artery hypertension
may be seen </span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>INR: Done to get baseline value before the commencement
of warfarin therapy</span></p>
<h2><span lang=EN-US>Management </span></h2>
<h3><span lang=EN-US>Management in Gate Clinic</span></h3>
<p class=MsoNormal><span lang=EN-US>All patients with features of a DVT or PE
should be referred immediately to the ward for urgent review by a doctor. </span></p>
<h3><span lang=EN-US>Management on the Ward</span></h3>
<p class=MsoNormal><span lang=EN-US>In suspected acute PE, commence intravenous
fluid and oxygen (if oxygen saturation &lt;88%).</span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>Heparin and warfarin should be started as soon as possible for
prophylaxis in high-risk patients or treatment after confirmed DVT or PE.
Heparin should be continued for at least 5 days or until 2 consecutive target
INR results are obtained. In pregnancy, only heparin is used</span></p>
<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:0cm;margin-bottom:.0001pt'><span lang=EN-US>Unfractionated
heparin can be given subCutaneously as 250 units/kg stat then every 12 hours.
It is the preferred option in patients with kidney disease. Enoxaparin can be
given subCutaneously as 1.5mg/kg/ dose OD.</span></p>
<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:0cm;margin-bottom:.0001pt'><span lang=EN-US>Monitor APTT(ideally,
every 6 hours)and adjust unfractionated heparin dose accordingly.</span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>Warfarin can be initiated with a once-daily dose between 2mg and
5mg. The maintenance dose of warfarin is usually between 2mg and 10mg once
daily.</span></p>
<p class=MsoNormal style='margin-top:12.0pt'><span lang=EN-US>Daily INR
monitoring should start from day 3 of initiation of therapy until INR is at
target for more than 2 consecutive readings.</span></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='margin-left:62.1pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=213 valign=top style='width:160.1pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Condition </span></b></p>
  </td>
  <td width=193 valign=top style='width:144.7pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Target INR</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=213 valign=top style='width:160.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>DVT prophylaxis</span></p>
  </td>
  <td width=193 valign=top style='width:144.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>2 – 2.5</span></p>
  </td>
 </tr>
 <tr>
  <td width=213 valign=top style='width:160.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>DVT or PE treatment</span></p>
  </td>
  <td width=193 valign=top style='width:144.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>2 – 3</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal style='margin-top:12.0pt'><span lang=EN-US>Thereafter, the frequency
of INR monitoring is twice weekly but can be reduced gradually to once-weekly,
once every 2 weeks, and then once monthly as long as the patient’s INR remains
within the therapeutic range. Warfarin doses should be adjusted according to
the INR results. More frequent monitoring is needed after any dose adjustment
until stable readings are obtained.</span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>Warfarin should be continued for at least 3 months. Warfarin therapy
should be extended beyond 3&nbsp;months for patients with unprovoked proximal
DVT or PE if their risk of recurrence is high and there is no additional risk
of major bleeding. </span></p>
<p class=MsoNormal style='margin-top:12.0pt'><span lang=EN-US>Paracetamol can
be prescribed for pain in DVT</span></p>
<p class=MsoNormal style='margin-top:12.0pt'><b><span lang=EN-US>&nbsp;</span></b></p>
<p class=MsoNormal style='margin-top:12.0pt'><b><span lang=EN-US>&nbsp;</span></b></p>
<p class=MsoNormal style='margin-top:12.0pt'><b><span lang=EN-US>Key Issues for
Nursing care</span></b></p>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Monitor vital signs every hour initially in
acute PE. This frequency may be reduced to every 4 hours as patient stabilizes.
</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Monitor vital signs once every shift in DVT. </span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurse  with affected leg elevated</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Avoid IM injections on the affected limb</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Strict fluid charts</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ensure enoxaparin is given at the same time
every day.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Be wary of heparin concentrations when
calculating doses</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Call the doctor if: </span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Temperature &gt; 38.5ºC</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Pulse &lt; 50 or &gt; 120 bpm</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Systolic blood pressure &lt; 90 or &gt;160 mmHg</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Diastolic blood pressure&lt; 60 or &gt;90 mmHg</span></p>
<p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Oxygen saturation &lt; 90%</span></p>
<h2><span lang=EN-US>References</span></h2>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>NICE Guidance for
Venous Thromboembolic Diseases </span><span lang=EN-US><a
href="https://www.nice.org.uk/guidance/cg144/chapter/recommendations#diagnosis-2"><span
style='font-size:10.0pt;color:windowtext;text-decoration:none'>https://www.nice.org.uk/guidance/cg144/chapter/recommendations#diagnosis-2</span></a></span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Aggarwal V,
Nicolais CD, Lee A; Bashir R. et al. Acute management of pulmonary embolism. </span><span
lang=EN-US><a
href="https://www.acc.org/latest-in-cardiology/articles/2017/10/23/12/12/acute-management-of-pulmonary-embolism"><span
style='font-size:10.0pt;color:windowtext;text-decoration:none'>https://www.acc.org/latest-in-cardiology/articles/2017/10/23/12/12/acute-management-of-pulmonary-embolism</span></a></span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Medscape.
Pulmonary Embolism </span><span lang=EN-US><a
href="https://emedicine.medscape.com/article/300901-overview"><span
style='font-size:10.0pt;color:windowtext;text-decoration:none'>https://emedicine.medscape.com/article/300901-overview</span></a></span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Diagnosis and
Management of Acute Deep Vein Thrombosis: A Joint Consensus Document From the
European Society of Cardiology Working Groups of Aorta and Peripheral
Circulation and Pulmonary Circulation and Right Ventricular Function. Eur Heart
J 2017; Feb 17:[Epub ahead of print].</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Antithrombotic
therapy and prevention of thrombosis, 9th ed: American College of Chest
Physicians evidence-based clinical practice guidelines.&nbsp;Chest.
2012;141(suppl 2).</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>&nbsp;</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Written by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Azeezat Sallahdeen</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 24 November 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Reviewed by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Fatai Akemokwe</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 30 January 2019</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Version:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Change history:</span></b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Review due date:</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>New document</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.1</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Executive summary added</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Review Comments (<i>if applicable)</i></span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>&nbsp;</span></b></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
</div>
</div><!-- /content -->

</div>

</body>
</html>
